Yako, Hideji
Niimi, Naoko
Kato, Ayako
Takaku, Shizuka
Tatsumi, Yasuaki
Nishito, Yasumasa
Kato, Koichi
Sango, Kazunori
Funding for this research was provided by:
the Ministry of Education, Science, Sports, Culture and Technology of Japan (20K16127, 20K07773)
the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University
the Nukada Institute for Medical and Biological Research
Sumitomo Dainippon Pharma Co., Ltd.
Article History
Received: 25 May 2021
Accepted: 3 September 2021
First Online: 23 September 2021
Competing interests
: Research funding for this study, as well as the AR inhibitor ranirestat and the data of intracellular sorbitol and fructose contents, were provided by Sumitomo Dainippon Pharma Co., Ltd (H. Y. and K. S.). The other authors declare no competing interests.